-
Je něco špatně v tomto záznamu ?
Biological Activities and ADMET-Related Properties of Novel Set of Cinnamanilides
J. Kos, A. Bak, V. Kozik, T. Jankech, T. Strharsky, A. Swietlicka, H. Michnova, J. Hosek, A. Smolinski, M. Oravec, F. Devinsky, M. Hutta, J. Jampilek
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
APVV-17-0373
Slovak Research and Development Agency
LO1305
Ministry of Education, Youth and Sports of the Czech Republic
APVV-0516-12
Slovak Research and Development Agency
CZ.02.1.01/0.0/0.0/16_019/0000797
SustES
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- ampicilin farmakologie MeSH
- analýza hlavních komponent MeSH
- antiflogistika farmakologie MeSH
- cinnamáty chemická syntéza MeSH
- inhibiční koncentrace 50 MeSH
- koncentrace vodíkových iontů MeSH
- lidé MeSH
- methicilin rezistentní Staphylococcus aureus účinky léků MeSH
- mikrobiální testy citlivosti MeSH
- mikrovlny MeSH
- molekulární modely MeSH
- Mycobacterium tuberculosis účinky léků MeSH
- NF-kappa B metabolismus MeSH
- Staphylococcus aureus účinky léků MeSH
- THP-1 buňky MeSH
- viabilita buněk účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- zánět MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
A series of nineteen novel ring-substituted N-arylcinnamanilides was synthesized and characterized. All investigated compounds were tested against Staphylococcus aureus as the reference strain, two clinical isolates of methicillin-resistant S. aureus (MRSA), and Mycobacterium tuberculosis. (2E)-N-[3-Fluoro-4-(trifluoromethyl)phenyl]-3-phenylprop-2-enamide showed even better activity (minimum inhibitory concentration (MIC) 25.9 and 12.9 μM) against MRSA isolates than the commonly used ampicillin (MIC 45.8 μM). The screening of the cell viability was performed using THP1-BlueTM NF-κB cells and, except for (2E)-N-(4-bromo-3-chlorophenyl)-3-phenylprop-2-enamide (IC50 6.5 μM), none of the discussed compounds showed any significant cytotoxic effect up to 20 μM. Moreover, all compounds were tested for their anti-inflammatory potential; several compounds attenuated the lipopolysaccharide-induced NF-κB activation and were more potent than the parental cinnamic acid. The lipophilicity values were specified experimentally as well. In addition, in silico approximation of the lipophilicity values was performed employing a set of free/commercial clogP estimators, corrected afterwards by the corresponding pKa calculated at physiological pH and subsequently cross-compared with the experimental parameters. The similarity-driven property space evaluation of structural analogs was carried out using the principal component analysis, Tanimoto metrics, and Kohonen mapping.
Central Mining Institute Pl Gwarkow 1 40166 Katowice Poland
Department of Chemistry University of Silesia Szkolna 9 40007 Katowice Poland
Faculty of Pharmacy Comenius University Odbojarov 10 83232 Bratislava Slovakia
Global Change Research Institute CAS Belidla 986 4a 60300 Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020138
- 003
- CZ-PrNML
- 005
- 20230914142949.0
- 007
- ta
- 008
- 210728s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules25184121 $2 doi
- 035 __
- $a (PubMed)32916979
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kos, Jiri $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 78371 Olomouc, Czech Republic
- 245 10
- $a Biological Activities and ADMET-Related Properties of Novel Set of Cinnamanilides / $c J. Kos, A. Bak, V. Kozik, T. Jankech, T. Strharsky, A. Swietlicka, H. Michnova, J. Hosek, A. Smolinski, M. Oravec, F. Devinsky, M. Hutta, J. Jampilek
- 520 9_
- $a A series of nineteen novel ring-substituted N-arylcinnamanilides was synthesized and characterized. All investigated compounds were tested against Staphylococcus aureus as the reference strain, two clinical isolates of methicillin-resistant S. aureus (MRSA), and Mycobacterium tuberculosis. (2E)-N-[3-Fluoro-4-(trifluoromethyl)phenyl]-3-phenylprop-2-enamide showed even better activity (minimum inhibitory concentration (MIC) 25.9 and 12.9 μM) against MRSA isolates than the commonly used ampicillin (MIC 45.8 μM). The screening of the cell viability was performed using THP1-BlueTM NF-κB cells and, except for (2E)-N-(4-bromo-3-chlorophenyl)-3-phenylprop-2-enamide (IC50 6.5 μM), none of the discussed compounds showed any significant cytotoxic effect up to 20 μM. Moreover, all compounds were tested for their anti-inflammatory potential; several compounds attenuated the lipopolysaccharide-induced NF-κB activation and were more potent than the parental cinnamic acid. The lipophilicity values were specified experimentally as well. In addition, in silico approximation of the lipophilicity values was performed employing a set of free/commercial clogP estimators, corrected afterwards by the corresponding pKa calculated at physiological pH and subsequently cross-compared with the experimental parameters. The similarity-driven property space evaluation of structural analogs was carried out using the principal component analysis, Tanimoto metrics, and Kohonen mapping.
- 650 _2
- $a ampicilin $x farmakologie $7 D000667
- 650 _2
- $a antiflogistika $x farmakologie $7 D000893
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a cinnamáty $x chemická syntéza $7 D002934
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a zánět $7 D007249
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a methicilin rezistentní Staphylococcus aureus $x účinky léků $7 D055624
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a mikrovlny $7 D008872
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a Mycobacterium tuberculosis $x účinky léků $7 D009169
- 650 _2
- $a NF-kappa B $x metabolismus $7 D016328
- 650 _2
- $a analýza hlavních komponent $7 D025341
- 650 _2
- $a Staphylococcus aureus $x účinky léků $7 D013211
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a THP-1 buňky $7 D000074084
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bak, Andrzej $u Department of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland
- 700 1_
- $a Kozik, Violetta $u Department of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland
- 700 1_
- $a Jankech, Timotej, $u Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 84215 Bratislava, Slovakia $d 1996- $7 xx0306913
- 700 1_
- $a Strharsky, Tomas $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 78371 Olomouc, Czech Republic
- 700 1_
- $a Swietlicka, Aleksandra $u Department of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland
- 700 1_
- $a Michnova, Hana $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 78371 Olomouc, Czech Republic
- 700 1_
- $a Hosek, Jan $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 78371 Olomouc, Czech Republic
- 700 1_
- $a Smolinski, Adam $u Central Mining Institute, Pl. Gwarkow 1, 40166 Katowice, Poland
- 700 1_
- $a Oravec, Michal $u Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic
- 700 1_
- $a Devinsky, Ferdinand $u Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia
- 700 1_
- $a Hutta, Milan $u Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 84215 Bratislava, Slovakia
- 700 1_
- $a Jampilek, Josef $u Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 84215 Bratislava, Slovakia
- 773 0_
- $w MED00180394 $t Molecules $x 1420-3049 $g Roč. 25, č. 18 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32916979 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20230914142944 $b ABA008
- 999 __
- $a ok $b bmc $g 1690846 $s 1140584
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 25 $c 18 $e 20200909 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a APVV-17-0373 $p Slovak Research and Development Agency
- GRA __
- $a LO1305 $p Ministry of Education, Youth and Sports of the Czech Republic
- GRA __
- $a APVV-0516-12 $p Slovak Research and Development Agency
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000797 $p SustES
- LZP __
- $a Pubmed-20210728